Abstract: The present invention relates to a novel magnesium-serinate compound and the use thereof, and more particularly, to a novel magnesium-serinate compound in which a magnesium atom is chelated to L-serine, and the pharmaceutical use thereof against central nervous system diseases or the like.
Type:
Grant
Filed:
February 12, 2019
Date of Patent:
July 14, 2026
Assignee:
Astrogen Co., Ltd.
Inventors:
Su-Kyeong Hwang, Min Yong Lee, Min Sook Seo, Do Youn Jun, Min Joo Kim, Young Ho Kim, Young Kyoung Jo